Search

Author/Creator Du, Ying-Ying

1. Combined LIM kinase 1 and p21-Activated kinase 4 inhibitor treatment exhibits potent preclinical antitumor efficacy in breast cancer. (28th November 2020)

Authors:
Zhao, Chen-Chen; Zhan, Meng-Na; Liu, Wan-Ting; Jiao, Yang; Zhang, Yi-Yin; Lei, Yu; Zhang, Teng-Teng; Zhang, Cong-Jun; Du, Ying-Ying; Gu, Kang-Sheng; Wei, Wei
Journal:
Cancer letters
Issue:
Volume 493(2020)
Page Start:
120
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Potassium-doped PC71BM for hydrogen storage: Photoelectron spectroscopy and first-principles studies. (6th April 2021)

Authors:
Lin, De-Qu; Wang, Long-Xi; Song, Cheng-Hui; Du, Ying-Ying; Chen, Guang-Hua; Liu, Chen; Wang, Jia-Ou; Wu, Rui; Qian, Hai-Jie; Ibrahim, Kurash; Li, Hong-Nian
Journal:
International journal of hydrogen energy
Issue:
Volume 46:Number 24(2021)
Page Start:
13061
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. The radiosensitizing effect of Paeonol on lung adenocarcinoma by augmentation of radiation-induced apoptosis and inhibition of the PI3K/Akt pathway. (December 2013)

Authors:
Lei, Yu; Li, Hong-Xia; Jin, Wen-Sen; Peng, Wan-Ren; Zhang, Cong-Jun; Bu, Li-Jia; Du, Ying-Ying; Ma, Tai; Sun, Guo-Ping
Journal:
International journal of radiation biology
Issue:
Volume 89:Number 12(2013:Dec.)
Page Start:
1079
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗